Related references
Note: Only part of the references are listed.Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein
Mark J. Bolland et al.
CLINICAL ENDOCRINOLOGY (2007)
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: A prospective, randomized clinical trial
Elena Ambrogini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The emerging role of the fibroblast growth factor-23-Klotho axis in renal regulation of phosphate homeostasis
Mohammed S. Razzaque et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism
D. W. Dempster et al.
BONE (2007)
Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism:: A prospective, randomized trial
Jens Bollerslev et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism
Thomas K. Barthel et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function
B. Moosgaard et al.
CLINICAL ENDOCRINOLOGY (2007)
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk - a meta-analysis
P. Vestergaard et al.
OSTEOPOROSIS INTERNATIONAL (2007)
The effects of smoking on bone health
Peter K. K. Wong et al.
CLINICAL SCIENCE (2007)
Mouse Osteoblastic Cell Line (MC3T3-E1) Expresses Extracellular Calcium (Ca2+o)-Sensing Receptor and Its Agonists Stimulate Chemotaxis and Proliferation of MC3T3-E1 Cells
Toru Yamaguchi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Minireview: vitamin D receptor: New assignments for an already busy receptor
Anthony W. Norman
ENDOCRINOLOGY (2006)
The risk of fractures in postmenopausal women with primary hyperparathyroidism
Simona De Geronimo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
Elizabeth Barrett-Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyrolidism
P. Boudou et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women
I Charopoulos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism
N Özbey et al.
WORLD JOURNAL OF SURGERY (2006)
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: An update on the changing epidemiology of the disease
RA Wermers et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism
K Kobayashi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Current pharmacological options for the management of primary hyperparathyroidism
Peter Vestergaard
DRUGS (2006)
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism
B Moosgaard et al.
CLINICAL ENDOCRINOLOGY (2005)
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
J Cunningham et al.
KIDNEY INTERNATIONAL (2005)
Smoking and hormones in health and endocrine disorders
D Kapoor et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency
A Grey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in Hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study
JS Lindberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism
H Kaji et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism
M Peacock et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
GA Block et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism - Are they too limited?
MS Eigelberger et al.
ANNALS OF SURGERY (2004)
Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk
S Sarkar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism
H Yamashita et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial
AA Khan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study
P Vestergaard et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy
A Sitges-Serra et al.
WORLD JOURNAL OF SURGERY (2004)
Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism
DS Rao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Calcimimetics and the treatment of primary and secondary hyperparathyroidism
MS Joy et al.
ANNALS OF PHARMACOTHERAPY (2004)
The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region
H Raef et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
Calcium and 1,25(OH)2D:: interacting drivers of epidermal differentiation
DD Bikle et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism
E Nordenström et al.
WORLD JOURNAL OF SURGERY (2004)
Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
JA Cauley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects
QX Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism
P Vestergaard et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects
JC Souberbielle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Short- and long-term changes in bone mineral density of the lumbar spine after parathyroidectomy in patients with primary hyperparathyroidism
F Lumachi et al.
CALCIFIED TISSUE INTERNATIONAL (2003)
Influence of renal function on clinico-pathological features of primary hyperparathyroidism
H Yamashita et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Fractures in patients with primary hyperparathyroidism: Nationwide follow-up study of 1201 patients
P Vestergaard et al.
WORLD JOURNAL OF SURGERY (2003)
Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism
MR Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism
CC Chow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Regulation of 25-hydroxyvitamin D3-24-Hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone
C Zierold et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Update on genetic and clinical aspects of primary hyperparathyroidism
S Miedlich et al.
CLINICAL ENDOCRINOLOGY (2003)
The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism
DM Shoback et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
T Larsson et al.
KIDNEY INTERNATIONAL (2003)
Multifactorial risk profile for bone fractures in primary hyperparathyroidism
E Nordenström et al.
WORLD JOURNAL OF SURGERY (2002)
Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: A 2-year study
CR Parker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Vitamin D status in Japanese patients with hyperparathyroidism: Seasonal changes and effect on clinical presentation
H Yamashita et al.
WORLD JOURNAL OF SURGERY (2002)
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
PD Delmas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Meta-analysis of alendronate for the treatment of postmenopausal women
A Cranney et al.
ENDOCRINE REVIEWS (2002)
Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis
A Cranney et al.
ENDOCRINE REVIEWS (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Sex steroids and the construction and conservation of the adult skeleton
BL Riggs et al.
ENDOCRINE REVIEWS (2002)
Parathyroid hormone-dependent signaling pathways regulating genes in bone cells
JT Swarthout et al.
GENE (2002)
Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women
AG Need et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect
FH Glorieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: Evidence for parathyroid hormone-related protein and receptor activator of NF-kappa B-dependent effects on osteoclast formation in regenerating mammalian bone
C Faucheux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers
EM Hauge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications
P Lips
ENDOCRINE REVIEWS (2001)
Vitamin D status and redefining serum parathyroid hormone reference range in the elderly
JC Souberbielle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor in human bone
MC Langub et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Longitudinal evaluation of vitamin D status in healthy subjects from Southern Italy: Seasonal and gender differences
V Carnevale et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Clinical vignette - Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism
JR Zanchetta et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism
M Rossini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism
V Kantorovich et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism
P Vestergaard et al.
BRITISH MEDICAL JOURNAL (2000)
Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism -: Four-year follow-up and comparison with healthy postmenopausal women
BJ Orr-Walker et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Primary hyperparathyroidism: Bone structure, balance, and remodeling before and 3 years after surgical treatment
T Steiniche et al.
BONE (2000)
Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism
D Nakaoka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Effect of vitamin D nutrition on parathyroid adenoma weight: Pathogenetic and clinical implications
DS Rao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Smoking and bone metabolism in elderly women
PB Rapuri et al.
BONE (2000)
Share Paper
